Skip to Content

DAN A22 (Ranitidine Hydrochloride 150 mg)

Pill with imprint DAN A22 is Yellow, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Schein.

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DAN A22

Ranitidine hydrochloride 150 mg DAN A22  Front
Ranitidine hydrochloride 150 mg DAN A22  Back

Ranitidine Hydrochloride

Imprint
DAN A22
Strength
150 mg
Color
Yellow
Shape
Round
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Schein
National Drug Code (NDC)
00364-2633

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.